{"news_desk": "Business", "print_page": "1", "subsection_name": null, "section_name": "Business Day", "byline": {"contributor": "Katie Thomas contributed reporting.", "original": "By ANDREW POLLACK", "person": [{"firstname": "Andrew", "rank": 1, "lastname": "POLLACK", "organization": "", "role": "reported"}]}, "abstract": "Pharmaceutical company Mylan takes unusual step of offering generic version of its own product EpiPen in effort to counter indignation provoked by price increase; critics assert generic version's price still exceeds its manufacturing costs and is prohibitive for low-income patients who rely on it to treat extreme allergic reactions.", "type_of_material": "News", "word_count": "1221", "keywords": [{"rank": "1", "value": "Mylan Inc", "is_major": "Y", "name": "organizations"}, {"rank": "2", "value": "Medical Devices", "is_major": "N", "name": "subject"}, {"rank": "3", "value": "Epinephrine (Drug)", "is_major": "Y", "name": "subject"}, {"rank": "4", "value": "Prices (Fares, Fees and Rates)", "is_major": "N", "name": "subject"}, {"rank": "5", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "name": "subject"}, {"rank": "6", "value": "Generic Brands and Products", "is_major": "Y", "name": "subject"}, {"rank": "7", "value": "Allergies", "is_major": "Y", "name": "subject"}], "lead_paragraph": "Critics are still not mollified after the pharmaceutical maker introduced a generic competitor to its own branded product, EpiPen, at half the price.", "pub_date": "2016-08-30T04:00:00+0000", "document_type": "article", "source": "The New York Times", "snippet": "Critics are still not mollified after the pharmaceutical maker introduced a generic competitor to its own branded product, EpiPen, at half the price....", "multimedia": [], "web_url": "http://www.nytimes.com/2016/08/30/business/mylan-generic-epipen.html", "slideshow_credits": null, "blog": [], "_id": "57c6f8b395d0e021d798325e", "headline": {"main": "Mylan Tries Again to Quell Pricing Outrage by Offering Generic EpiPen", "print_headline": "Mylan Tries to Silence Outrage  by Offering a Generic EpiPen"}}